Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab.
作者信息
Cook Lucy B M, Demontis Maria Antonietta, Sagawe Sophie, Witkover Aviva, Melamed Anat, Turpin Jocelyn, Dillon Richard, Haddow Jana, Marks Alexandra J, Bangham Charles R M, Fields Paul, Taylor Graham P, Rowan Aileen G
机构信息
Section of Virology, Department of Medicine, Imperial College London.
Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital.
出版信息
Haematologica. 2019 Dec;104(12):e566-e569. doi: 10.3324/haematol.2019.219253. Epub 2019 Apr 19.
Abstract
摘要
相似文献
1
Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab.在用莫加莫珠单抗治疗的慢性成人T细胞白血病/淋巴瘤患者中观察到分子缓解。
Haematologica. 2019 Dec;104(12):e566-e569. doi: 10.3324/haematol.2019.219253. Epub 2019 Apr 19.
2
Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.莫格利珠单抗用于治疗复发或难治性成人T细胞白血病-淋巴瘤。
Expert Rev Hematol. 2017 Sep;10(9):757-760. doi: 10.1080/17474086.2017.1361819. Epub 2017 Aug 21.
3
Mogamulizumab for the treatment of T-cell lymphoma.莫加莫拉单抗用于治疗T细胞淋巴瘤。
Expert Opin Biol Ther. 2017 Sep;17(9):1145-1153. doi: 10.1080/14712598.2017.1347634. Epub 2017 Jul 3.
4
[Pharmacological and clinical profile of mogamulizumab (POTELIGEO(®) Injection)].[莫格利珠单抗（POTELIGEO®注射剂）的药理及临床概况]
Nihon Yakurigaku Zasshi. 2013 Feb;141(2):100-5. doi: 10.1254/fpj.141.100.
5
Ascites Retention during Mogamulizumab Treatment in a Patient with Adult T-cell Leukemia/lymphoma.莫加莫珠单抗治疗成人T细胞白血病/淋巴瘤患者期间的腹水潴留
Intern Med. 2016;55(13):1793-6. doi: 10.2169/internalmedicine.55.5987. Epub 2016 Jul 1.
6
[Adult T-cell leukemia-lymphoma with severe hepatic damage and fluid retention successfully treated with mogamulizumab].
Rinsho Ketsueki. 2020;61(6):612-616. doi: 10.11406/rinketsu.61.612.
7
Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient.莫加莫拉单抗单药治疗一名成人T细胞白血病/淋巴瘤患者过程中CCR4表达缺失的分子分析
Ann Hematol. 2015 Apr;94(4):693-5. doi: 10.1007/s00277-014-2239-1. Epub 2014 Oct 23.
8
Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T-Cell Lymphoma or Adult T-Cell Lymphoma.莫格利珠单抗治疗皮肤 T 细胞淋巴瘤或成人 T 细胞淋巴瘤患者的群体药代动力学建模。
J Clin Pharmacol. 2020 Jan;60(1):58-66. doi: 10.1002/jcph.1564. Epub 2019 Dec 16.
9
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.异基因造血干细胞移植后复发的成人 T 细胞白血病/淋巴瘤采用 mogamulizumab 或来那度胺治疗：长崎移植组的经验。
Hematol Oncol. 2020 Apr;38(2):162-170. doi: 10.1002/hon.2712. Epub 2020 Jan 26.
10
Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma.莫格利珠单抗治疗成人 T 细胞白血病/淋巴瘤。
Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):326-331. doi: 10.1016/j.clml.2019.03.004. Epub 2019 Mar 23.
引用本文的文献
1
HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma.HTLV-1 持续感染与成人 T 细胞白血病/淋巴瘤的发生。
Blood. 2023 May 11;141(19):2299-2306. doi: 10.1182/blood.2022019332.
2
A new paradigm for the management of ATL.成人T细胞白血病/淋巴瘤（ATL）治疗的新范式
Br J Haematol. 2022 Sep;198(6):941-942. doi: 10.1111/bjh.18363. Epub 2022 Jul 15.
3
Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.全面基因组分析鉴定外周 T 细胞淋巴瘤的异质性。
Cancer Sci. 2021 Apr;112(4):1339-1347. doi: 10.1111/cas.14849. Epub 2021 Feb 25.
4
HTLV-1 as a Model for Virus and Host Coordinated Immunoediting.人类嗜 T 细胞病毒 1 作为病毒和宿主协同免疫编辑的模型。
Front Immunol. 2019 Sep 24;10:2259. doi: 10.3389/fimmu.2019.02259. eCollection 2019.
本文引用的文献
1
Mogamulizumab investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.莫格利珠单抗治疗复发/难治性成人 T 细胞白血病/淋巴瘤的化疗方案选择。
Haematologica. 2019 May;104(5):993-1003. doi: 10.3324/haematol.2018.205096. Epub 2018 Dec 20.
2
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.与莫格利珠单抗治疗下成人T细胞白血病/淋巴瘤的较好预后相关的CCR4突变。
Blood. 2018 Aug 16;132(7):758-761. doi: 10.1182/blood-2018-02-835991. Epub 2018 Jun 21.
3
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.在成年慢性T细胞白血病/淋巴瘤患者中，停用齐多夫定和干扰素-α治疗后长期临床缓解得以维持。
Int J Hematol. 2018 Mar;107(3):378-382. doi: 10.1007/s12185-017-2361-7. Epub 2017 Oct 31.
4
Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.莫格利珠单抗治疗复发的成人T细胞白血病-淋巴瘤：I期和II期研究的更新随访分析
Cancer Sci. 2017 Oct;108(10):2022-2029. doi: 10.1111/cas.13343. Epub 2017 Aug 28.
5
T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.T细胞受体Vβ染色可识别成人T细胞白血病中的恶性克隆，并揭示自体CD8 + T细胞对白血病细胞的杀伤作用。
PLoS Pathog. 2016 Nov 28;12(11):e1006030. doi: 10.1371/journal.ppat.1006030. eCollection 2016 Nov.
6
Integrated molecular analysis of adult T cell leukemia/lymphoma.成人 T 细胞白血病/淋巴瘤的综合分子分析。
Nat Genet. 2015 Nov;47(11):1304-15. doi: 10.1038/ng.3415. Epub 2015 Oct 5.
7
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.功能获得性 CCR4 突变在成人 T 细胞白血病/淋巴瘤中的作用。
J Exp Med. 2014 Dec 15;211(13):2497-505. doi: 10.1084/jem.20140987. Epub 2014 Dec 8.
8
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.人嗜T淋巴细胞病毒1型（HTLV-1）克隆性、前病毒结构及基因组整合位点在成人T细胞白血病/淋巴瘤中的作用
Blood. 2014 Jun 19;123(25):3925-31. doi: 10.1182/blood-2014-02-553602. Epub 2014 Apr 15.
9
Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.1型人类嗜T细胞病毒载量变异性以及无症状携带者和1型人类嗜T细胞病毒相关疾病患者的长期趋势
AIDS Res Hum Retroviruses. 2013 Feb;29(2):359-64. doi: 10.1089/AID.2012.0132. Epub 2012 Sep 25.
10
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.去岩藻糖基化抗 CCR4 单克隆抗体（KW-0761）治疗复发成人 T 细胞白血病/淋巴瘤：一项多中心 II 期研究。
J Clin Oncol. 2012 Mar 10;30(8):837-42. doi: 10.1200/JCO.2011.37.3472. Epub 2012 Feb 6.
Zotero 插件